COVID-19肺炎后的慢性肺损伤:临床、影像与组织病理学视角
综述指出COVID-19大流行1年内住院患者中24%-54%在感染1年后影像仍见磨玻璃影、网格影、支气管扩张和空气潴留,最高50%患者有残留症状及生理功能受损。持续呼吸道症状而常规CT正常者,双能增强CT、氙129 MRI和低场强MRI可显示通气或灌注异常。组织学可见纤维化、机化性肺炎和血管异常。
要点
- 感染1年后24%-54%住院患者CT可见磨玻璃影、网格影、支气管扩张和空气潴留。
- 持续呼吸道症状但常规CT正常者,双能增强CT、氙129 MRI和低场强MRI可显示通气或灌注异常。
- 组织学模式包括纤维化、机化性肺炎和血管异常,提示不同病理机制参与PCC。
核心结论
- COVID-19肺炎后慢性肺损伤在临床、影像和组织病理上表现多样,部分肺损伤常规CT无法检出,需综合影像方法评估持续症状患者。
研究设计与样本
- 综述,聚焦COVID-19幸存者长期临床和影像异常表现及组织病理学视角,并涉及先进影像技术和深度学习方法。
关键影像表现/征象
- 感染1年后影像可见磨玻璃影、网格影、支气管扩张和空气潴留。
- 持续呼吸道症状而常规CT正常者,双能增强CT、氙129 MRI和低场强MRI可显示通气或灌注异常。
- 组织学模式包括纤维化、机化性肺炎和血管异常。
临床应用与阅片要点
- 对持续COVID-19症状患者,可采用综合影像方法评估和诊断。
- 常规CT正常但持续呼吸道症状者,可考虑双能增强CT、氙129 MRI和低场强MRI评估通气和灌注异常。
局限性
- 该领域仍是活跃研究领域,需进一步随访研究以更好理解疾病慢性阶段并制定多学科患者管理方法。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
With the COVID-19 pandemic having lasted more than 3 years, concerns are growing about prolonged symptoms and respiratory complications in COVID-19 survivors, collectively termed post-COVID-19 condition (PCC). Up to 50% of patients have residual symptoms and physiologic impairment, particularly dyspnea and reduced diffusion capacity. Studies have also shown that 24%-54% of patients hospitalized during the 1st year of the pandemic exhibit radiologic abnormalities, such as ground-glass opacity, reticular opacity, bronchial dilatation, and air trapping, when imaged more than 1 year after infection. In patients with persistent respiratory symptoms but normal results at chest CT, dual-energy contrast-enhanced CT, xenon 129 MRI, and low-field-strength MRI were reported to show abnormal ventilation and/or perfusion, suggesting that some lung injury may not be detectable with standard CT. Histologic patterns in post-COVID-19 lung disease include fibrosis, organizing pneumonia, and vascular abnormality, indicating that different pathologic mechanisms may contribute to PCC. Therefore, a comprehensive imaging approach is necessary to evaluate and diagnose patients with persistent post-COVID-19 symptoms. This review will focus on the long-term findings of clinical and radiologic abnormalities and describe histopathologic perspectives. It also addresses advanced imaging techniques and deep learning approaches that can be applied to COVID-19 survivors. This field remains an active area of research, and further follow-up studies are warranted for a better understanding of the chronic stage of the disease and developing a multidisciplinary approach for patient management.
引用
- Cha MJ, Solomon JJ, Lee JE, et al. Chronic Lung Injury after COVID-19 Pneumonia: Clinical, Radiologic, and Histopathologic Perspectives. Radiology. 2024. PMID: 38193836. doi:10.1148/radiol.231643
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。